HeartWare International, Inc. , a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to commence enrollment in an additional patient cohort ... (more)
http://www.benzinga.com/news/13/08/3867603/heartware-wins-fda-approval-to-enroll-supplemental-patient-cohort-in-destination-
http://www.benzinga.com/news/13/08/3867603/heartware-wins-fda-approval-to-enroll-supplemental-patient-cohort-in-destination-
No comments:
Post a Comment